The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital
NCT ID: NCT01602744
Last Updated: 2014-04-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
382 participants
INTERVENTIONAL
2012-04-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Potentially Inappropriate Prescribing in Late Life Using Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) Criteria
NCT00915824
Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients
NCT01467050
Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis
NCT07202962
Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.
NCT03393299
Reducing CNS-Active Medications to Prevent Falls and Injuries in Older Adults
NCT05689554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controll
The medications in this arm will not be screened.
No interventions assigned to this group
Intervention screening medication group
STOPP/START screening tools are used for medication intervention
STOPP/START screening tools for medication intervention
In the intervention arm the investigator will use the screening tools STOPP/START to screen the medications.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STOPP/START screening tools for medication intervention
In the intervention arm the investigator will use the screening tools STOPP/START to screen the medications.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* live in the geriatric hospital "Givaat Hashlosha" permanently.
Exclusion Criteria
* people who enter the geriatric hospital for a short while (are not permanent).
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolfson Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariella Herskowits, MBA
Role: PRINCIPAL_INVESTIGATOR
Wolfson Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Givaat Hashlosha Geriatric Hospital
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0036-12 WOMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.